Home Hereditary vitamin D rickets: a case series in a family
Article
Licensed
Unlicensed Requires Authentication

Hereditary vitamin D rickets: a case series in a family

  • Kumar Surender , I.P.S. Kochar EMAIL logo , Ayesha Ahmad and Meenal Kapoor
Published/Copyright: July 9, 2014

Abstract

Hereditary vitamin D-resistant rickets (HVDRR) is an autosomal recessive disorder characterized by end-organ resistance to 1α,25-dihydroxyvitamin D3 (1,25D3). Clinically, the syndrome is recognized by severe early onset rickets with bowing of the lower extremities, short stature, and often alopecia. Here, we report a case series on three siblings who had HVDRR with varied clinical findings.


Corresponding author: Dr. I.P.S. Kochar, Division of Endocrinology, Apollo Centre for Advanced Pediatrics, Indraprastha Apollo Hospital, New Delhi 110044, India, Phone: +91-99-102-40919, E-mail:

References

1. Malloy PJ, Pike JW, Feldman D. The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocr Rev 1999;20:156–88.Search in Google Scholar

2. McDonnell DP, Scott RA, Kerner SA, O’Malley BW, Pike JW. Functional domains of the human vitamin D3 receptor regulate osteocalcin gene expression. Mol Endocrinol 1989;3:635–44.10.1210/mend-3-4-635Search in Google Scholar

3. Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh J-C, et al. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J Endocrinol 1997;154:S57–73.Search in Google Scholar

4. Rosen JF, Fleischman AR, Finberg L, Hamstra A, DeLuca HF. Rickets with alopecia: an inborn error of vitamin D metabolism. J Pediatr 1979;94:729–35.10.1016/S0022-3476(79)80139-0Search in Google Scholar

5. Liberman UA, Samuel R, Halabe A, Kauli R, Edelstein S, et al. End-organ resistance to 1,25-dihydroxycholecalciferol. Lancet 1980;1:504–6.10.1016/S0140-6736(80)92763-4Search in Google Scholar

6. Sockalosky JJ, Ulstrom RA, DeLuca HF, Brown DM. Vitamin D-resistant rickets: end-organ unresponsiveness to 1,25(OH)2D3. J Pediatr 1980;96:701–3.10.1016/S0022-3476(80)80748-7Search in Google Scholar

7. Kudoh T, Kumagai T, Uetsuji N, Tsugawa S, Oyanagi K, et al. Vitamin D dependent rickets: decreased sensitivity to 1,25-dihydroxyvitamin D. Eur J Pediatr 1981;137:307–11.10.1007/BF00443263Search in Google Scholar

8. Balsan S, Garabedian M, Liberman UA, Eil C, Bourdeau A, et al. Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D: two different clinical courses with two different cellular defects. J Clin Endocrinol Metab 1983;57:803–11.10.1210/jcem-57-4-803Search in Google Scholar

9. Laufer D, Benderly A, Hochberg Z. Dental pathology in calcitirol resistant rickets. J Oral Med 1987;42:272–5.Search in Google Scholar

10. Bliziotes M, Yergey AL, Nanes MS, Muenzer J, Begley MG, et al. Absent intestinal response to calciferols in hereditary resistance to 1,25- dihydroxyvitamin D: documentation and effective therapy with high dose intravenous calcium infusions. J Clin Endocrinol Metab 1988;66:294–300.10.1210/jcem-66-2-294Search in Google Scholar

11. Hochberg Z, Benderli A, Levy J, Vardi P, Weisman Y, et al. 1,25- Dihydroxyvitamin D resistance, rickets, and alopecia. Am J Med 1984;77:805–11.10.1016/0002-9343(84)90516-3Search in Google Scholar

12. Hochberg Z, Gilhar A, Haim S, Friedman-Birnbaum R, Levy J, et al. Calcitriol-resistant rickets with alopecia. Arch Dermatol 1985;121:646–7.10.1001/archderm.1985.01660050098023Search in Google Scholar

13. Marx SJ, Bliziotes MM, Nanes M. Analysis of the relation between alopecia and resistance to 1,25-dihydroxyvitamin D. Clin Endocrinol (Oxf) 1986;25:373–81.10.1111/j.1365-2265.1986.tb01703.xSearch in Google Scholar PubMed

14. Bergman R, Schein-Goldshmid R, Hochberg Z, Ben-Izhak O, Sprecher E. The alopecias associated with vitamin D-dependent rickets type IIA and with hairless gene mutations: a comparative clinical, histologic, and immunohistochemical study. Arch Dermatol 2005;141: 343–51.10.1001/archderm.141.3.343Search in Google Scholar

15. Miller J, Djabali K, Chen T, Liu Y, Ioffreda M, et al. Atrichia caused by mutations in the vitamin D receptor gene is a phenocopy of generalized atrichia caused by mutations in the hairless gene. J Invest Dermatol 2001;117:612–17.10.1046/j.0022-202x.2001.01438.xSearch in Google Scholar

16. Malloy PJ, Feldman D. The role of vitamin D receptor mutations in the development of alopecia. Mol Cell Endocrinol 2011;5;347:90–6.10.1016/j.mce.2011.05.045Search in Google Scholar

17. Hochberg Z, Tiosano D, Even L. Calcium therapy for calcitriol-resistant rickets. J Pediatr 1992;121:803–8.10.1016/S0022-3476(05)81919-5Search in Google Scholar

18. Nicolaidou P, Tsitsika A, Papadimitriou A, Karantana A, Papadopoulou A, et al. Hereditary vitamin D-resistant rickets in Greek children: genotype, phenotype, and long-term response to treatment. J Pediatr Endocrinol Metab 2007;20:425–30.10.1515/JPEM.2007.20.3.425Search in Google Scholar PubMed

19. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011;96:53–8.10.1210/jc.2010-2704Search in Google Scholar PubMed PubMed Central

20. Huang K, Malloy P, Feldman D, Pitukcheewanont P. Enteral calcium infusion used successfully as treatment for a patient with hereditary vitamin D resistant rickets (HVDRR) without alopecia: a novel mutation. Gene 2013;512: 554–9.10.1016/j.gene.2012.09.078Search in Google Scholar PubMed

21. Srivastava T, Alon US. Cinacalcet as adjunctive therapy for hereditary 1,25-dihydroxyvitamin D-resistant rickets. J Bone Miner Res 2013;28:992–6.10.1002/jbmr.1838Search in Google Scholar PubMed

Received: 2013-11-18
Accepted: 2014-6-13
Published Online: 2014-7-9
Published in Print: 2014-11-1

©2014 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Highlight: Cushing syndrome
  3. Fundamental principles of clinical and biochemical evaluation underlie the diagnosis and therapy of Cushing’s syndrome
  4. Cushing syndrome secondary to CRH-producing Wilms tumor in a 6 year old
  5. Cushing’s disease presenting as cholestatic hepatitis
  6. How early can one diagnose Cushing’s disease? An early diagnosis in a case of prepubertal Cushing’s disease
  7. Review article
  8. Subclinical hypothyroidism in childhood and adolescense
  9. Original articles
  10. Energy substrate metabolism in pyruvate dehydrogenase complex deficiency
  11. Chromosome 6q24 transient neonatal diabetes mellitus and protein sensitive hyperinsulinaemic hypoglycaemia
  12. Measures of pituitary gland and stalk: from neonate to adolescence
  13. Are preterm newborns who have relative hyperthyrotropinemia at increased risk of brain damage?
  14. Pseudohypoparathyroidism vs. tricho-rhino-phalangeal syndrome: patient reclassification
  15. Association of serum 25-hydroxyvitamin D with race/ethnicity and constitutive skin color in urban schoolchildren
  16. A nonsense thyrotropin receptor gene mutation (R609X) is associated with congenital hypothyroidism and heart defects
  17. Acanthosis nigricans, vitamin D, and insulin resistance in obese children and adolescents
  18. Clinical characteristics and chromosome 11p15 imprinting analysis of Silver-Russell syndrome – a Chinese experience
  19. Change in reference body mass index percentiles and deviation in overweight and obesity over 3 years in Turkish children and adolescents
  20. Long-term outcomes of pediatric Graves’ disease
  21. Accessibility of the reference center as a protective factor against ketoacidosis at the onset of diabetes in children
  22. Vitamin D, parathormone, and insulin resistance in children born large for gestational age
  23. Prevalence of vitamin D deficiency in apparently healthy children in north India
  24. Prevalence of autoantibodies in type 1 diabetes patients and its association with the clinical presentation – UAE Eastern Region experience
  25. Clinical and molecular studies related to bone metabolism in patients with congenital adrenal hyperplasia
  26. Islet neogenesis-associated protein-related pentadecapeptide improves the function of allograft after islets transplantation
  27. Anti-Mullerian hormone may be a useful adjunct in the diagnosis of polycystic ovary syndrome in nonobese adolescents
  28. Early infant feeding practice and childhood obesity: the relation of breast-feeding and timing of solid food introduction with childhood obesity
  29. Late onset X-linked adrenal hypoplasia congenita with hypogonadotropic hypgonadism due to a novel 4-bp deletion in exon 2 of NR0B1
  30. The correlation between GnRH stimulation testing and obstetric ultrasonographic parameters in precocious puberty
  31. The DATAC study: a new growth database. Description of the epidemiology, diagnosis and therapeutic attitude in a group of Spanish children with short stature
  32. Concentrations of tumour necrosis factor-α and its soluble receptors in the serum of teenagers with atherosclerosis risk factors: obesity or obesity combined with hypertension
  33. Are HDL levels lower in children with type 1 diabetes and concurrent celiac disease compared with children with type 1 diabetes only?
  34. Patient reports
  35. Hereditary vitamin D rickets: a case series in a family
  36. Two heterozygous mutations of the AMH gene in a Japanese patient with persistent Müllerian duct syndrome
  37. Two case reports of severe pediatric hyperosmolar hyperglycemia and diabetic ketoacidosis accompanied with rhabdomyolysis and acute renal failure
  38. Acquired hypothyroidism due to iodine deficiency in an American child
  39. Continuous subcutaneous IGF-1 therapy via insulin pump in a patient with Donohue syndrome
  40. Amylase/creatinine clearance ratio in diabetic ketoacidosis: a case report
  41. Worsening hypertriglyceridemia with oral contraceptive pills in an adolescent with HIV-associated lipodystrophy: a case report and review of the literature
  42. Congenital hyperinsulinism in a newborn with a novel homozygous mutation (p.Q392H) in the ABCC8 gene
  43. Short communications
  44. Polyglandular autoimmune syndrome type I – a novel AIRE mutation in a North American patient
  45. Post-hemorrhagic hydrocephalus and diabetes insipidus in preterm infants
  46. Two novel mutations in acid α-glucosidase gene in two patients with Pompe disease
  47. Letter to the Editor
  48. And what about septin 9 (SEPT9) as a binding partner of survivin in heart regeneration?
Downloaded on 4.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0448/html
Scroll to top button